Acquisition of 440 mg injectable monoclonal drug Trastuzumab for cancer patients Chuquisaca Institute of Oncology corresponding to the first four months
Acquisition of Injectable Cytostatic Medication Paclitaxel 30 Mg for Oncological Patients Chuquisaqueño Institute of Oncology Corresponding to the First Quarter